Vascular Aging Clinical Trial
Official title:
Clinical Translation of Nitrite Therapy to Treat Arterial Aging in Humans
The proposed research will determine the effectiveness of nitrite, a naturally occurring compound in the body, for improving the health and function of arteries in middle-aged and older adults. The study also will provide insight into how sodium nitrite therapy improves artery health by determining the physiological mechanisms (biological reasons) involved. Overall, the proposed research will provide important new scientific evidence on the effectiveness of sodium nitrite for decreasing the risk of developing cardiovascular diseases with aging.
The improvement in blood vessel function and stiffness will be determined over a 10 week period. Subjects will be randomly assigned to either placebo (0 mg/day), low dose (80 mg/day) or high dose (160 mg/day) sodium nitrite. Main outcome measures will be performed at baseline and week 10. ;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04413994 -
Exclusive Human-milk in Preterm NEOnates and Early VASCular Aging Risk Factors (NEOVASC)
|
N/A | |
| Completed |
NCT01575288 -
Oral Trehalose Therapy to Reverse Arterial Aging in Middle-Aged and Older Adults
|
N/A | |
| Active, not recruiting |
NCT01968564 -
Oral Curcumin Supplementation in Middle-Aged and Older Adults Improves Vascular Function
|
N/A | |
| Completed |
NCT02795624 -
Vascular Aging in Flight Attendants With Occupational Secondhand Smoke Exposure
|
||
| Recruiting |
NCT05296395 -
Vascular Aging and Lp299v Study
|
N/A |